| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.045 | 0.8 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |